XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XRTX XORTX Therapeutics Inc.

休市中 12-20 15:58:51 EST

1.09

-0.01

-0.91%

盘后1.06

-0.03-2.75%

16:03 EST

最高1.20	最低1.09	成交量1.35万
今开1.11	昨收1.10	日振幅10.02%
总市值379.47万	流通市值321.93万	总股本348.14万
成交额1.51万	换手率0.46%	流通股本295.35万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XRTX","market":"US","secType":"STK","nameCN":"XORTX Therapeutics Inc.","latestPrice":1.09,"timestamp":1734728331224,"preClose":1.1,"halted":0,"volume":13460,"hourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.09,"latestTime":"16:03 EST","volume":100,"amount":106,"timestamp":1734728595758},"delay":0,"floatShares":2953500,"shares":3481375,"eps":-0.287836,"marketStatus":"休市中","marketStatusCode":7,"change":-0.01,"latestTime":"12-20 15:58:51 EST","open":1.11,"high":1.2002,"low":1.09,"amount":15138.65717,"amplitude":0.100182,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.287836,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"adjPreClose":1.1,"postHourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.09,"latestTime":"16:03 EST","volume":100,"amount":106,"timestamp":1734728595758},"volumeRatio":0.7192031418853871},"requestUrl":"/m/hq/s/XRTX","defaultTab":"news","newsList":[{"id":"2491470371","title":"Xortx Therapeutics Inc.盘中异动 股价大涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491470371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491470371?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:32","pubTimestamp":1734100329,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时32分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨6.03%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223209a1ec32f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223209a1ec32f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2490043314","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.74%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490043314?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:44","pubTimestamp":1733841890,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时44分，Xortx Therapeutics Inc.股票出现异动，股价快速上涨5.74%。截至发稿，该股报1.25美元/股，成交量2165股，换手率0.07%，振幅1.69%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224451984b0c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224451984b0c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0},{"id":"2489976234","title":"Xortx Therapeutics Inc.盘中异动 股价大涨6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489976234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489976234?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:06","pubTimestamp":1733429217,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时06分，Xortx Therapeutics Inc.股票出现异动，股价急速上涨6.84%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206040658a1d731b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206040658a1d731b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","XRTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2488761194","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨7.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488761194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488761194?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:31","pubTimestamp":1733322698,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时31分，Xortx Therapeutics Inc.股票出现异动，股价大幅拉升7.50%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223142abf5c863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223142abf5c863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2488775166","title":"Xortx Therapeutics Inc.盘中异动 股价大涨10.24%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488775166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488775166?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149901,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时31分，Xortx Therapeutics Inc.股票出现异动，股价快速拉升10.24%。截至发稿，该股报1.40美元/股，成交量7597股，换手率0.24%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223141abf00089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223141abf00089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2486271001","title":"Xortx Therapeutics Inc.盘中异动 早盘快速上涨6.67%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486271001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486271001?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:48","pubTimestamp":1732632490,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时48分，Xortx Therapeutics Inc.股票出现异动，股价急速上涨6.67%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Protagenic Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Elevai Labs, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为15.92%、13.27%、12.98%，振幅较大的相关个股有Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.、Cabaletta Bio, Inc.，振幅分别为29.32%、24.59%、19.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224811a2574dd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224811a2574dd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0},{"id":"2485514293","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485514293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485514293?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:54","pubTimestamp":1732290873,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时54分，Xortx Therapeutics Inc.股票出现波动，股价大幅下挫5.14%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.51%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112223543398e44310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112223543398e44310&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","XRTX"],"gpt_icon":0},{"id":"2484760916","title":"Xortx Therapeutics Inc.盘中异动 急速下跌6.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484760916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484760916?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:31","pubTimestamp":1731951067,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时31分，Xortx Therapeutics Inc.股票出现异动，股价快速跳水6.81%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119013107abccf984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119013107abccf984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2481303104","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅上涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481303104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481303104?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:46","pubTimestamp":1731077191,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时46分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨6.21%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463198e417da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822463198e417da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2481184496","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨6.90%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184496?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:02","pubTimestamp":1730991729,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时02分，Xortx Therapeutics Inc.股票出现异动，股价快速上涨6.90%。截至发稿，该股报1.55美元/股，成交量545股，换手率0.02%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107230209971a51be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107230209971a51be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2480340582","title":"Xortx Therapeutics Inc.盘中异动 早盘急速下挫6.99%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480340582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480340582?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:59","pubTimestamp":1730732375,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时59分，Xortx Therapeutics Inc.股票出现波动，股价快速下跌6.99%。截至发稿，该股报1.33美元/股，成交量1002股，换手率0.03%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225935ab9ecba6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225935ab9ecba6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2477371543","title":"Xortx Therapeutics Inc.盘中异动 大幅上涨5.26%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477371543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477371543?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:32","pubTimestamp":1729603922,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时32分，Xortx Therapeutics Inc.股票出现波动，股价急速拉升5.26%。截至发稿，该股报1.80美元/股，成交量1316股，换手率0.05%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222132029f56b990&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222132029f56b990&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2476212776","title":"Xortx Therapeutics Inc.盘中异动 早盘大幅下挫5.99%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476212776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476212776?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171897,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Xortx Therapeutics Inc.股票出现波动，股价快速下跌5.99%。截至发稿，该股报2.04美元/股，成交量6957股，换手率0.24%，振幅0.46%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721313795afa7cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721313795afa7cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2474746364","title":"Xortx Therapeutics Inc.盘中异动 股价大跌8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474746364?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:33","pubTimestamp":1728567211,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时33分，Xortx Therapeutics Inc.股票出现异动，股价急速下跌8.82%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021333198e3bb6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101021333198e3bb6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","XRTX","LENZ"],"gpt_icon":0},{"id":"2474406715","title":"Xortx Therapeutics Inc.盘中异动 下午盘股价大涨10.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474406715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474406715?lang=zh_cn&edition=full","pubTime":"2024-10-09 01:32","pubTimestamp":1728408730,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日01时32分，Xortx Therapeutics Inc.股票出现波动，股价大幅上涨10.46%。截至发稿，该股报1.69美元/股，成交量1.2064万股，换手率0.42%，振幅3.92%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100901321098e3b39a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100901321098e3b39a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XRTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2472574379","title":"Xortx Therapeutics Inc.股价拉升11.10% 市值涨54.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472574379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472574379?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:50","pubTimestamp":1728049803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时50分，Xortx Therapeutics Inc.股票出现波动，股价大幅拉升11.10%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004215003958fb571&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004215003958fb571&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","XRTX","BK4007"],"gpt_icon":0},{"id":"2471385321","title":"Xortx Therapeutics Inc.盘中异动 急速拉升7.73%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471385321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471385321?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:45","pubTimestamp":1727703906,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时45分，Xortx Therapeutics Inc.股票出现波动，股价快速上涨7.73%。截至发稿，该股报1.67美元/股，成交量493股，换手率0.02%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214506ab6727ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214506ab6727ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","XRTX"],"gpt_icon":0},{"id":"2470469984","title":"Xortx Therapeutics Inc.盘中异动 股价大涨5.18%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470469984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470469984?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:18","pubTimestamp":1727205492,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时18分，Xortx Therapeutics Inc.股票出现波动，股价快速拉升5.18%。截至发稿，该股报1.73美元/股，成交量2.7292万股，换手率0.94%，振幅8.23%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409250318129719c710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409250318129719c710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0},{"id":"2468884570","title":"Xortx Therapeutics Inc.盘中异动 早盘股价大涨5.20%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468884570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468884570?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:32","pubTimestamp":1726752730,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时32分，Xortx Therapeutics Inc.股票出现波动，股价急速拉升5.20%。截至发稿，该股报1.82美元/股，成交量1552股，换手率0.05%，振幅0.00%。Xortx Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Xortx Therapeutics Inc.公司简介：XORTX Therapeutics Inc 是一家临床阶段的生物技术公司，专注于识别、开发并可能商业化治疗由异常的嘌呤和尿酸代谢以及在罕见（孤儿）疾病指征如 ADPKD 和 T2DN 中的尿酸代谢调节的进行性肾脏疾病，以及与呼吸道病毒感染相关的急性肾损伤的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213210956fa307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213210956fa307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","XRTX"],"gpt_icon":0},{"id":"2465523700","title":"爱奇艺体育致歉！","url":"https://stock-news.laohu8.com/highlight/detail?id=2465523700","media":"大河财立方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465523700?lang=zh_cn&edition=full","pubTime":"2024-09-05 22:52","pubTimestamp":1725547936,"startTime":"0","endTime":"0","summary":"9月5日晚间，爱奇艺体育微博发文称，非常抱歉在今晚世预赛亚洲区18强赛中国男足首场客场对阵日本队的直播中，因球迷的热情，造成瞬时流量过大。我们的技术服务资源分配超出限额，给部分用户造成了不好的观赛体验。后续会进一步加强技术预案和运营能力，给大家提供更稳定可靠的直播服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409053176854230.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0856984785.SGD","HK0000320264.USD","BK1609","LU0348735423.USD","LU0831093199.SGD","BK4505","HK0000306701.USD","LU0348825331.USD","LU0823426308.USD","LU0326950275.SGD","LU0228367735.SGD","BK4531","LU0039217434.USD","LU0456827905.SGD","LU0287142896.SGD","LU0762542818.HKD","BK4552","LU0072462343.USD","LU0359202008.SGD","LU0762541174.USD","BK1575","LU0320764599.SGD","LU0823426480.USD","LU1115378108.SGD","LU0821914370.USD","LU0708995583.HKD","HK0000306685.HKD","IE0034224299.USD","LU2778985437.USD","LU0043850808.USD","BK1587","LU0630378429.USD","LU0762540952.USD","LU0417516902.SGD","BK1095","LU1048588211.SGD","89888","LU0173614495.USD","BK4108","LU2039709279.SGD","LU0307460666.USD","XRTX","BK4526","LU0229945570.USD","SG9999002828.SGD","LU0819121731.USD","LU0588546209.SGD","LU1328615791.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.xortx.com","stockEarnings":[{"period":"1week","weight":-0.084},{"period":"1month","weight":-0.1349},{"period":"3month","weight":-0.3771},{"period":"6month","weight":-0.481},{"period":"1year","weight":-0.5134},{"period":"ytd","weight":-0.5281}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XORTX Therapeutics Inc.于2012年8月24日根据加拿大艾伯塔省的法律注册成立，名称为ReVasCor Inc.在2018年1月10日，公司名称更改为“XORTX Therapeutics Inc.”。该公司是一家临床阶段的生物技术公司，专注于识别、开发和商业化治疗由异常嘌呤和尿酸代谢调节的进行性肾脏疾病的疗法，这些肾脏适应症包括ADPKD、冠状病毒COVID-19感染引起的AKI和T2DN。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.16276},{"month":2,"riseRate":0.333333,"avgChangeRate":0.063564},{"month":3,"riseRate":0.666667,"avgChangeRate":0.130043},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.089007},{"month":5,"riseRate":0.666667,"avgChangeRate":0.012197},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.062719},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.024783},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059348},{"month":9,"riseRate":0,"avgChangeRate":-0.142465},{"month":10,"riseRate":0,"avgChangeRate":-0.308198},{"month":11,"riseRate":0.25,"avgChangeRate":-0.090311},{"month":12,"riseRate":0,"avgChangeRate":-0.096612}],"exchange":"NASDAQ","name":"XORTX Therapeutics Inc.","nameEN":"XORTX Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"XORTX Therapeutics Inc.,XRTX,XORTX Therapeutics Inc.股票,XORTX Therapeutics Inc.股票老虎,XORTX Therapeutics Inc.股票老虎国际,XORTX Therapeutics Inc.行情,XORTX Therapeutics Inc.股票行情,XORTX Therapeutics Inc.股价,XORTX Therapeutics Inc.股市,XORTX Therapeutics Inc.股票价格,XORTX Therapeutics Inc.股票交易,XORTX Therapeutics Inc.股票购买,XORTX Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"XORTX Therapeutics Inc.(XRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供XORTX Therapeutics Inc.(XRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}